Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype
about
Protein kinase cascades in the regulation of cardiac hypertrophyThe heterotrimeric G q protein-coupled angiotensin II receptor activates p21 ras via the tyrosine kinase-Shc-Grb2-Sos pathway in cardiac myocytesAngiotensin II type1a receptor gene expression in the heart: AP-1 and GATA-4 participate in the response to pressure overloadAndrogen receptor (AR) in cardiovascular diseasesObesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunitiesTranscriptional pathways and potential therapeutic targets in the regulation of Ncx1 expression in cardiac hypertrophy and failureThe influence of Angiotensin converting enzyme and angiotensinogen gene polymorphisms on hypertrophic cardiomyopathyUpdate on RAAS Modulation for the Treatment of Diabetic Cardiovascular DiseaseSerine-910 phosphorylation of focal adhesion kinase is critical for sarcomere reorganization in cardiomyocyte hypertrophyCardiac defects contribute to the pathology of spinal muscular atrophy modelsSpecific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitroSystemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptorsInteraction of G-protein βγ complex with chromatin modulates GPCR-dependent gene regulationLosartan prevents heart fibrosis induced by long-term intensive exercise in an animal modelUrotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediatorsCurcumin prevents and reverses murine cardiac hypertrophyANG II stimulates phospholipase D through PKCzeta activation in VSMC: implications in adhesion, spreading, and hypertrophyN-acetylcysteine attenuates PKCbeta2 overexpression and myocardial hypertrophy in streptozotocin-induced diabetic ratsPeroxisome proliferator-activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitroEssential role of PKC-zeta in normal and angiotensin II-accelerated neointimal growth after vascular injuryA thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin IIAngiotensin induces the urinary peristaltic machinery during the perinatal periodEffects of triiodo-thyronine on angiotensin-induced cardiomyocyte hypertrophy: reversal of increased beta-myosin heavy chain gene expressionA nonpeptide angiotensin II type 2 receptor agonist does not attenuate postmyocardial infarction left ventricular remodeling in mice.Interaction between bradykinin subtype 2 and angiotensin II type 2 receptors during post-MI left ventricular remodeling.Differential effects of late-life initiation of low-dose enalapril and losartan on diastolic function in senescent Fischer 344 x Brown Norway male rats.Effects of short-term treadmill exercise training or growth hormone supplementation on diastolic function and exercise tolerance in old ratsMyocardial changes after spironolactone in spontaneous hypertensive rats. A laser scanning confocal microscopy study.Src is required for mechanical stretch-induced cardiomyocyte hypertrophy through angiotensin II type 1 receptor-dependent β-arrestin2 pathways.Changes of c-fos and c-jun mRNA expression in angiotensin II-induced cardiomyocyte hypertrophy and effects of sodium tanshinone IIA sulfonate.Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivationIntramyocardial fibroblast myocyte communication.Regression of left ventricular hypertrophy; what are appropriate therapeutic objectives?Piperine Attenuates Pathological Cardiac Fibrosis Via PPAR-γ/AKT Pathways.Association of the common genetic polymorphisms and haplotypes of the chymase gene with left ventricular mass in male patients with symptomatic aortic stenosis.Effects of hypertension and exercise on cardiac proteome remodellingContext Dependent Effects of Chimeric Peptide Morpholino Conjugates Contribute to Dystrophin Exon-skipping EfficiencyPractical considerations of the pharmacology of angiotensin receptor blockers.Cardiac hypertrophy: signal transduction, transcriptional adaptation, and altered growth control.Age-dependent expression of collagen receptors and deformation of type I collagen substrates by rat cardiac fibroblasts.
P2860
Q24518494-C53AD739-AA76-472E-ACAF-7D1773D7445AQ24562884-437A7F6D-F013-4777-8268-8D0528CB13DFQ24654964-E6077C9A-F6AB-43FA-841F-3FCC5BB26134Q26771962-39741349-FE44-447E-9079-2A32D7BBDC36Q26825697-F412BEE2-A091-46A5-91B8-79E82FAC062EQ26850165-8193E6E8-8B02-4B52-9970-CC50134399D2Q27002339-4A3D5BCD-FCD4-44BD-AC0C-EECD7CAED8F0Q28077454-8A39D96F-DADA-4B14-9153-498E2E51BA8FQ28248750-5170F439-44BF-469C-BD2C-27B609F05086Q28290032-1BB21CF1-58AC-48B3-9449-3D90F19410EBQ28344062-0CBBCF3C-D9A3-42E5-AFEA-5EFF2FE92A6BQ28364369-1AA9F050-5419-4FB3-8527-C7FEDF9304BFQ28484925-B4DFDA24-AF7C-4659-A6BC-D9791F2328CDQ28485917-70A7A30E-9558-498F-A6BE-ACA9D93EDD23Q28566263-DBCA6BDF-3674-430C-90A5-56C01400E10AQ28570267-23985542-7E51-4F92-AEFF-0A864CD16E65Q28571340-FDD2BE31-AC84-481D-A84E-6C26E58DD40AQ28573358-344F35E8-B75A-4C34-B4D5-56A97280C64EQ28577768-F4C8E0E4-315C-4B6C-90F8-ABC3C96418B9Q28579623-E8810ABC-B22F-4A52-A3CA-A3EEB5DB65B8Q28583200-D4633EC7-AA5E-409A-9DE7-394B13EFCF16Q28592988-E7A48A99-6FFF-4EB2-8386-676F8F8B1A81Q29144220-5153B474-6A8E-433F-A2FE-133B992CF710Q30421609-23F2F3C8-FBB8-4825-83C6-325A27BE1FCAQ30444722-599F8377-8D9D-4695-92EE-B2D33CF41B27Q30451313-4414ED52-8003-441D-8A8A-3E572FE81E6CQ30483339-D5E552CF-23EE-4015-9B45-61D7D994D1D8Q31052911-FEFF9AF0-A71A-4F61-A738-AEBB5C39E39EQ31156054-CDBB02D5-1927-45E2-BAFF-8B156CF7C525Q33375099-DB87871A-ECD3-4E24-B5D6-44A5324C976FQ33574889-FCB97F15-8C27-468E-8C0D-4AC6BA3B27C6Q33586605-69E16802-D181-4856-A2AC-69307F70D53FQ33586708-A71667D8-9407-44DA-8515-167FA524208BQ33603596-77392321-7155-43B4-99D1-05A286AFB1C5Q33604328-57894248-2930-4D0F-9536-3E1F038DB2CEQ33616482-51113940-0E9C-46B5-9322-02EAD07A466DQ33637391-1B9B5C59-1115-49CB-90DD-F91DA5E5C8AAQ33650699-F2ABDBFE-E67F-4E65-9135-68D8BD4BEEA6Q33692375-F425BA3F-BC02-4BA5-BF46-DD5CD153E81FQ33711061-78DB1805-3C12-493A-835C-4CD1854D813B
P2860
Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype
description
1993 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1993
@ast
im September 1993 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1993/09/01)
@sk
vědecký článek publikovaný v roce 1993
@cs
wetenschappelijk artikel (gepubliceerd op 1993/09/01)
@nl
наукова стаття, опублікована у вересні 1993
@uk
مقالة علمية (نشرت في سبتمبر 1993)
@ar
name
Molecular characterization of ...... le of the AT1 receptor subtype
@ast
Molecular characterization of ...... le of the AT1 receptor subtype
@en
Molecular characterization of ...... le of the AT1 receptor subtype
@nl
type
label
Molecular characterization of ...... le of the AT1 receptor subtype
@ast
Molecular characterization of ...... le of the AT1 receptor subtype
@en
Molecular characterization of ...... le of the AT1 receptor subtype
@nl
prefLabel
Molecular characterization of ...... le of the AT1 receptor subtype
@ast
Molecular characterization of ...... le of the AT1 receptor subtype
@en
Molecular characterization of ...... le of the AT1 receptor subtype
@nl
P3181
P356
P1433
P1476
Molecular characterization of ...... le of the AT1 receptor subtype
@en
P2093
J. Sadoshima
P304
P3181
P356
10.1161/01.RES.73.3.413
P577
1993-09-01T00:00:00Z